Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Williams

Showing results (191-200 of 204) with videos related to

Pageof 21
Sort By:
European Journal of Human Genetics : EJHG|October 14, 2024
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centresCristina Fortuno, Elisa J Cops, Aimee L Davidson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activitySuzanne J F Kaptein, Sofie Jacobs, Lana Langendries, et al.
Stroke|July 21, 2025
Rural and Urban Disparities in Access to Endovascular Thrombectomy for Large Vessel Occlusions in ColoradoDanielle Hagedorn, Michelle Whaley, Kristen Zuelke, et al.
BMJ Open Respiratory Research|September 21, 2021
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort studyOliver Stirrup, Florencia Boshier, Cristina Venturini, et al.
Journal of Medicinal Chemistry|April 3, 2025
Development of Next-Generation Antimalarial Acridones with Radical Cure PotentialRozalia A Dodean, Yuexin Li, Xiaowei Zhang, et al.
Nature Communications|February 23, 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatientsJoseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, et al.
Elife|September 13, 2022
Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective studyOliver Stirrup, James Blackstone, Fiona Mapp, et al.
The Journal of Infection|October 5, 2021
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital studyFlorencia A T Boshier, Cristina Venturini, Oliver Stirrup, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2023
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndromeRomy Walker, Khalid Mahmood, Jihoon E Joo, et al.
Journal of Translational Medicine|April 26, 2023
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndromeRomy Walker, Khalid Mahmood, Jihoon E Joo, et al.
Pageof 21

Showing results (191-200 of 204) with videos related to

Sort By:
Pageof 21
European Journal of Human Genetics : EJHG|October 14, 2024
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centresCristina Fortuno, Elisa J Cops, Aimee L Davidson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activitySuzanne J F Kaptein, Sofie Jacobs, Lana Langendries, et al.
Stroke|July 21, 2025
Rural and Urban Disparities in Access to Endovascular Thrombectomy for Large Vessel Occlusions in ColoradoDanielle Hagedorn, Michelle Whaley, Kristen Zuelke, et al.
BMJ Open Respiratory Research|September 21, 2021
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort studyOliver Stirrup, Florencia Boshier, Cristina Venturini, et al.
Journal of Medicinal Chemistry|April 3, 2025
Development of Next-Generation Antimalarial Acridones with Radical Cure PotentialRozalia A Dodean, Yuexin Li, Xiaowei Zhang, et al.
Nature Communications|February 23, 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatientsJoseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, et al.
Elife|September 13, 2022
Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective studyOliver Stirrup, James Blackstone, Fiona Mapp, et al.
The Journal of Infection|October 5, 2021
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital studyFlorencia A T Boshier, Cristina Venturini, Oliver Stirrup, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2023
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndromeRomy Walker, Khalid Mahmood, Jihoon E Joo, et al.
Journal of Translational Medicine|April 26, 2023
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndromeRomy Walker, Khalid Mahmood, Jihoon E Joo, et al.
Pageof 21